000			01263 a2200337 4500
005			20250516223133.0
264		0	_c20140904
008			201409s 0 0 ger d
022			_a1438-3276
040			_aNLM _beng _cNLM
245	0	0	_a[Therapy spectrum in hepatitis C extended. Newer NS3/4A protease inhibitor in chronic hepatitis C-GT1/4 infection]. _h[electronic resource]
260			_bMMW Fortschritte der Medizin _cJun 2014
300			_a53 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article
650	0	4	_aAntiviral Agents _xadverse effects
650	0	4	_aDrug Therapy, Combination
650	0	4	_aHepacivirus _xdrug effects
650	0	4	_aHepatitis C, Chronic _xdrug therapy
650	0	4	_aHeterocyclic Compounds, 3-Ring _xadverse effects
650	0	4	_aHumans
650	0	4	_aInterferons _xadverse effects
650	0	4	_aProtease Inhibitors _xadverse effects
650	0	4	_aRandomized Controlled Trials as Topic
650	0	4	_aRibavirin _xadverse effects
650	0	4	_aSecondary Prevention
650	0	4	_aSimeprevir
650	0	4	_aSofosbuvir
650	0	4	_aSulfonamides _xadverse effects
650	0	4	_aUridine Monophosphate _xadverse effects
773	0		_tMMW Fortschritte der Medizin _gvol. 156 Suppl 1 _gp. 53
999			_c24009448 _d24009448